The large majority of studies have focused on the role of IL-1beta (β) (main released isoform) and demonstrated that interleukin-1 beta isoform (IL-1β) is a primary mediator of central and peripheral inflammation after stroke [7]. This evidence concerns the gene IL1B and Stroke.